A miniaturized flow-through cell to evaluate skin permeation of endoxifen

Ahmad, 2010, Orally administered endoxifen is a new therapeutic agent for breast cancer, Breast Cancer Res. Treat., 122, 579, 10.1007/s10549-009-0704-7 Ahmad, 2010, Endoxifen, a new cornerstone of breast cancer therapy: demonstration of safety, tolerability, and systemic bioavailability in healthy human subjects, Clin. Pharmacol. Ther., 88, 814, 10.1038/clpt.2010.196 Akazawa, 1989, An automated method for continuously monitoring diffusion cells in skin penetration studies, Int. J. Pharm., 50, 53, 10.1016/0378-5173(89)90181-6 Aranda, 2011, Development of a methodology to quantify tamoxifen and endoxifen in breast cancer patients by micellar liquid chromatography and validation according to the ICH guidelines, Talanta, 84, 314, 10.1016/j.talanta.2011.01.022 Aungst, 1986, Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides, Int. J. Pharm., 33, 225, 10.1016/0378-5173(86)90057-8 Barry, 1991, Lipid–protein-partitioning theory of skin penetration enhancement, J. Control. Release, 15, 237, 10.1016/0168-3659(91)90115-T Bartosova, 2012, Transdermal drug delivery in vitro using diffusion cells, Curr. Med. Chem., 19, 4662, 10.2174/092986712803306358 Bellantone, 1986, Enhanced percutaneous-absorption via iontophoresis. 1. Evaluation of an in vitro system and transport of model compounds, Int. J. Pharm., 30, 63, 10.1016/0378-5173(86)90136-5 Brain, 1993, Molecular modeling of skin permeation enhancement by chemical agents, 389 Brand, 2003, Sunscreens containing physical UV blockers can increase transdermal absorption of pesticides, Toxicol. Ind. Health, 19, 9, 10.1191/0748233703th169oa Bronaugh, 1993, Diffusion cell design, 120, 10.1007/978-1-4899-1262-6_6 Bronaugh, 1985, Methods for in vitro percutaneous absorption studies IV: the flow-through diffusion cell, J. Pharm. Sci., 74, 64, 10.1002/jps.2600740117 COLIPA, 1997. http://www.cosmeticseurope.eu/publications-cosmetics-europe-association/guidelines.html?view=item&id=26 (accessed 02.04.12). Cordoba-Diaz, 2000, Validation protocol of an automated in-line flow-through diffusion equipment for in vitro permeation studies, J. Control. Release, 69, 357, 10.1016/S0168-3659(00)00306-0 Del Re, 2011, Pharmacogenetics of anti-estrogen treatment of breast cancer, Cancer Treat. Rev., 38, 442, 10.1016/j.ctrv.2011.08.003 Desta, 2004, Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6, J. Pharmacol. Exp. Ther., 310, 1062, 10.1124/jpet.104.065607 EBCTCG-Secretariat, 2005, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials, Lancet, 365, 1687, 10.1016/S0140-6736(05)66544-0 Godin, 2007, Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models, Adv. Drug Deliv. Rev., 59, 1152, 10.1016/j.addr.2007.07.004 Hanson, 2012. http://www.hansonresearch.com/ (accessed 26.06.12). Holmes, 2005, Pharmacogenomics of tamoxifen in a nutshell-and who broke the nutcracker?, J. Oncol. Pract., 1, 155, 10.1200/JOP.1.4.155 Hoskins, 2009, CYP2D6 and tamoxifen, DNA matters in breast cancer, Nat. Rev. Cancer, 9, 576, 10.1038/nrc2683 ICH, 1994. http://www.ich.org/products/guidelines/quality/quality-single/article/validation-of-analytical-procedures-text-and-methodology.html (accessed 20.02.12). Jemal, 2011, Global cancer statistics, CA Cancer J. Clin., 61, 69, 10.3322/caac.20107 Johnson, 2004, Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen, Breast Cancer Res. Treat., 85, 151, 10.1023/B:BREA.0000025406.31193.e8 Kang, 2008, Microfluidics for drug discovery and development: from target selection to product lifecycle management, Drug. Discov. Today, 13, 1, 10.1016/j.drudis.2007.10.003 Kang, 2007, Formulation development of transdermal dosage forms: quantitative structure-activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin, J. Control. Release, 120, 211, 10.1016/j.jconrel.2007.05.006 Krishnaiah, 2002, Effect of limonene on the in vitro permeation of nicardipine hydrochloride across the excised rat abdominal skin, Pharmazie, 57, 842 Lakowicz, 1994, Light quenching and fluorescence depolarization of rhodamine B and applications of this phenomenon to biophysics, J. Phys. Chem., 98, 334, 10.1021/j100052a055 Lee, 2011, In vitro human skin permeation of endoxifen: potential for local transdermal therapy for primary prevention and carcinoma in situ of the breast, Breast Cancer, 3, 61 Li, 2009, PDMS compound adsorption in context, J. Biomol. Screen., 14, 194, 10.1177/1087057108327326 Martin, 1989, A new diffusion cell – an automated method for measuring the pharmaceutical availability of topical dosage forms, Int. J. Pharm., 49, 63, 10.1016/0378-5173(89)90153-1 Moghimi, 1997, A lamellar matrix model for stratum corneum intercellular lipids. V. Effects of terpene penetration enhancers on the structure and thermal behaviour of the matrix, Int. J. Pharm., 146, 41, 10.1016/S0378-5173(96)04766-7 Ng, 2010, Validation of a static Franz diffusion cell system for in vitro permeation studies, AAPS PharmSciTech, 11, 1432, 10.1208/s12249-010-9522-9 NIH, U.S., 2009. http://clinicaltrials.gov/ct2/show/NCT00952731 (accessed 07.09.12). NIH, U.S., 2011a. http://clinicaltrials.gov/ct2/show/NCT01273168 (accessed 20.02.12). NIH, U.S., 2011b. http://clinicaltrials.gov/ct2/show/study/NCT01327781 (accessed 20.02.12). Panchagnula, 2001, Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin, Int. J. Pharm., 219, 95, 10.1016/S0378-5173(01)00634-2 Park, 2005, Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery, J. Control. Release, 104, 51, 10.1016/j.jconrel.2005.02.002 Permegear, 2012. http://www.permegear.com/ilc14.htm (accessed 26.06.12). Rapedius, 2001, Comparison of the Hanson Microette® and the Van Kel apparatus for in vitro release testing of topical semisolid formulations, Pharm. Res., 18, 1440, 10.1023/A:1012256923340 Šalamoun, 1990, Identification of products formed during UV irradiation of tamoxifen and their use for fluorescence detection in high-performance liquid chromatography, J. Chromatogr. A, 514, 179, 10.1016/S0021-9673(01)89389-4 Sanghvi, 1993, Comparison of diffusion studies of hydrocortisone between the Franz cell and the enhancer cell, Drug Dev. Ind. Pharm., 19, 1573, 10.3109/03639049309069327 Selzer, 2012, Finite and infinite dosing: difficulties in measurements, evaluations and predictions, Adv. Drug Deliv. Rev. Singh, 2011, Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes, Breast, 20, 111, 10.1016/j.breast.2010.11.003 Sznitowska, 2001, Studies on the effect of pH on the lipoidal route of penetration across stratum corneum, J. Control. Release, 76, 327, 10.1016/S0168-3659(01)00443-6 Tojo, 1987, Drug permeation across the skin: effect of penetrant hydrophilicity, J. Pharm. Sci., 76, 123, 10.1002/jps.2600760208 Tokumoto, 2005, Effect of electroporation on the electroosmosis across hairless mouse skin in vitro, J. Control. Release, 105, 296, 10.1016/j.jconrel.2005.04.002 Varshney, 1999, Effects of AOT micellar systems on the transdermal permeation of glyceryl trinitrate, Colloids Surf. B, 13, 1, 10.1016/S0927-7765(98)00100-3 Williams, 1992, Skin absorption enhancers, Crit. Rev. Ther. Drug Carrier Syst., 9, 305 Windheuser, 1982, The use of N,N-diethyl-m-toluamide to enhance dermal and transdermal delivery of drugs, J. Pharm. Sci., 71, 1211, 10.1002/jps.2600711107 Wong, 2009, Surface molecular property modifications for poly(dimethylsiloxane) (PDMS) based microfluidic devices, Microfluid. Nanofluid., 7, 291, 10.1007/s10404-009-0443-4 Wu, 2009, The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cells, Cancer Res., 69, 1722, 10.1158/0008-5472.CAN-08-3933 Zhao, 2000, Mechanism(s) of in vitro percutaneous absorption enhancement of tamoxifen by enhancers, J. Pharm. Sci., 89, 771, 10.1002/(SICI)1520-6017(200006)89:6<771::AID-JPS9>3.0.CO;2-Y